IP Library Granted Patent US 8,496,976
Granted Patent B2
US 8,496,976 · App. 13/376,374 · Granted Jul 30, 2013

Artificial tears and therapeutic uses

Inventors: Anuradha V. Gore (Irvine, CA); Robert S. Jordan (Trabuco Canyon, CA); Kevin Krock (Corona, CA); Chetan P. Pujara (Irvine, CA)
Assignee: Allergan, Inc.
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,496,976
App. No.
13/376,374
Granted
Jul 30, 2013
Kind
B2
Abstract

The present invention provides ophthalmic compositions, e.g. artificial tears, suitable for treating dry eye syndrome in a human or other mammal suffering there from, e.g. a dog or cat, which comprise a mixture of castor oil with another oil, e.g. a food oil, e.g. olive oil, sesame oil, corn oil etc.

Claims (15)

1. A composition for the treatment of dry eye syndrome in a human or mammal in need thereof, the composition consisting essentially of therapeutically effective amounts of:

linseed oil;

castor oil;

one or more tonicity agents selected from the group consisting of glycerin, erythritol, mannitol, sorbitol, xylitol, dextrose, carnitine, propylene glycol, sodium chloride, and potassium chloride;

one or more surfactants selected from the group consisting of polysorbate, polyoxyl stearate, glyceryl stearate, and isopropyl stearate;

one or more viscosity enhancers selected from the group consisting of carboxymethyl cellulose, hyaluronic acid, and crosslinked copolymers of acrylic acid and C10-C30 alkyl acrylate;

stabilized oxychloro complex; and,

at least one buffering and pH adjusting agent selected from the group consisting of hydrochloric acid, sodium hydroxide, boric acid, citrate salts, phosphate salts, lactate salts, and ammonium salts.

2. A composition for the treatment of dry eye syndrome in a human or mammal in need thereof, the composition consisting essentially of therapeutically effective amounts of:

linseed oil;

castor oil;

one or more tonicity agents selected from the group consisting of glycerin, erythritol, mannitol, sorbitol, xylitol, dextrose, carnitine, propylene glycol, sodium chloride, and potassium chloride;

one or more surfactants selected from the group consisting of polysorbate, polyoxyl stearate, glyceryl stearate, and isopropyl stearate;

one or more viscosity enhancers selected from the group consisting of carboxymethyl cellulose, hyaluronic acid, and crosslinked copolymers of acrylic acid and C10-C30 alkyl acrylate; and,

at least one buffering and pH adjusting agent selected from the group consisting of hydrochloric acid, sodium hydroxide, boric acid, citrate salts, phosphate salts, lactate salts, and ammonium salts.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 28, 2013
From: GORE, ANURADHA V.; JORDAN, ROBERT S.; KROCK, KEVIN; PUJARA, CHETAN
To: ALLERGAN, INC.
Reel/Frame 030713/0568 →
Continuity (2)
Provisional Application 61184339 · Jun 5, 2009
Related Publication 20120201910A1 · Aug 9, 2012